The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Invitae Corporation on May 7, 2024. The debtor has been authorized to sell its substantially all its assets to Labcorp Genetics Inc. for a purchase price of $239 million in cash plus reimbursement amount of $4 million. The purchaser is represented by William Intner, Jessica A. Bisignano and Erin N. Brady of Hogan Lovells US LLP as its legal advisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | +650.00% |
|
+650.00% | -99.52% |
13/06 | First Amended Disclosure Statement Approved for Invitae Corporation | CI |
11/06 | Motion for Exclusivity Period Extension Approved For Invitae Corporation | CI |
1st Jan change | Capi. | |
---|---|---|
-99.52% | 859K | |
-39.38% | 8.28B | |
+9.28% | 3.62B | |
-1.48% | 2.24B | |
-22.85% | 1.94B | |
-18.07% | 1.72B | |
+10.53% | 962M | |
+17.17% | 734M | |
-9.17% | 690M | |
-33.88% | 477M |
- Stock Market
- Equities
- NVTA.Q Stock
- News Invitae Corporation
- Motion for Asset Sale Approved for Invitae Corporation